CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 2. Expression of Evi1 protein in P19 transformant cells. P19 cells were transfected as described in "Materials and Methods." Each nuclear extract was subjected to SDS-PAGE, blotted to a filter, and probed with anti-pTEV1 antibody. Control P19 EC cells (P19 EC), vector-transfected P19 clones (Mock), and Evi1-transfected clones (clones P19/D2 and P19/D5) were grown as monolayers in the absence of 1 µM RA, and control P19 cells were cultured in the presence of 1 µM RA for 4 days after RA treatment [P19 RA (+) Day 4]. A human leukemia cell line (MOLM1) expressed Evi1 highly as a positive clone.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation